PL372964A1 - Nowe polimorficzne i pseudopolimorficzne postaci soli sodowej rizedronianu - Google Patents

Nowe polimorficzne i pseudopolimorficzne postaci soli sodowej rizedronianu

Info

Publication number
PL372964A1
PL372964A1 PL03372964A PL37296403A PL372964A1 PL 372964 A1 PL372964 A1 PL 372964A1 PL 03372964 A PL03372964 A PL 03372964A PL 37296403 A PL37296403 A PL 37296403A PL 372964 A1 PL372964 A1 PL 372964A1
Authority
PL
Poland
Prior art keywords
pseudopolymorphs
risedronate sodium
novel polymorphs
polymorphs
novel
Prior art date
Application number
PL03372964A
Other languages
English (en)
Inventor
Judith Aronhime
Revital Lifshitz-Liron
Eti Kovalevski-Ishai
Rami Lidor-Hadas
Original Assignee
Teva Pharmaceutical Indudstries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Indudstries, Ltd. filed Critical Teva Pharmaceutical Indudstries, Ltd.
Publication of PL372964A1 publication Critical patent/PL372964A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL03372964A 2002-04-11 2003-01-06 Nowe polimorficzne i pseudopolimorficzne postaci soli sodowej rizedronianu PL372964A1 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37246502P 2002-04-11 2002-04-11
US40417402P 2002-08-16 2002-08-16
US40566802P 2002-08-22 2002-08-22

Publications (1)

Publication Number Publication Date
PL372964A1 true PL372964A1 (pl) 2005-08-08

Family

ID=29255338

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372964A PL372964A1 (pl) 2002-04-11 2003-01-06 Nowe polimorficzne i pseudopolimorficzne postaci soli sodowej rizedronianu

Country Status (12)

Country Link
US (1) US20030195170A1 (pl)
EP (1) EP1492502A4 (pl)
JP (1) JP3803672B2 (pl)
KR (3) KR20040101447A (pl)
CN (2) CN1658842A (pl)
AU (1) AU2003209167A1 (pl)
CA (1) CA2480764A1 (pl)
HR (1) HRP20041051A2 (pl)
IL (1) IL164382A0 (pl)
MX (1) MXPA04010009A (pl)
PL (1) PL372964A1 (pl)
WO (1) WO2003086355A1 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ293349B6 (cs) 2002-10-25 2004-04-14 Léčiva, A.S. Nová krystalická forma sodné soli kyseliny 3-pyridyl-1-hydroxyethyliden-1,1-bisfosfonové
ATE402942T1 (de) * 2003-01-17 2008-08-15 Teva Pharma Verfahren zur reduzierung des eisengehalts bei risedronat natrium
WO2005066190A1 (en) * 2004-01-02 2005-07-21 Hexal A/S New risedronate salts
CZ298639B6 (cs) * 2004-02-05 2007-12-05 Zentiva, A. S. Krystalická forma risedronátu monosodného
PL1723157T5 (pl) † 2004-02-26 2018-01-31 Zentiva Ks Amorficzne postaci rizedronianu monosodowego
ES2289650T3 (es) 2004-03-03 2008-02-01 Chemi S.P.A. Sal monosodica del acido 3-piridil-1-hidroxietiliden-1,1-bifosfonico amorfa y procedimiento para la preparacion de la misma.
EP1828214A4 (en) * 2004-11-09 2008-08-13 Jubilant Organosys Ltd PROCESS FOR THE SYNTHESIS OF A PURE POLYMORPHIC FORM OF SODIUM 3-PYRIDYL-1-HYDROXYETHYLIDINE-1,1-BISPHOSPHONATE
PL199215B1 (pl) * 2004-12-28 2008-08-29 Politechnika Gdanska Sposób wytwarzania kwasu [1-hydroksy-2-(3-pirydylo)etylidenobisfosfonowego] oraz jego soli monosodowej dwu i pół wodnej
ES2324015T1 (es) * 2005-05-06 2009-07-29 Medichem, S.A. Proceso de sintesis de acidos bisfosfonicos geminales o de sus sales farmaceuticamente aceptables o de sus hidratos.
WO2006129056A2 (en) * 2005-05-28 2006-12-07 Pliva Hrvatska D.O.O Process and novel salt
EP1891081B1 (en) * 2005-06-13 2014-08-20 Jubilant Organosys Limited Process for producing bisphosphonic acids and forms thereof
WO2007026379A2 (en) * 2005-08-30 2007-03-08 Natco Pharma Limited Novel crystalline forms of risedronate monosodium
GB0519891D0 (en) * 2005-09-30 2005-11-09 Pliva Hrvatska D O O Pharmaceutically acceptable salts and hydrates
EP1775302A1 (en) 2005-10-11 2007-04-18 Sandoz A/S Method for preparing crystalline sodium risedronate
WO2007042048A2 (en) * 2005-10-11 2007-04-19 Sandoz A/S Method for preparing crystalline sodium risedronate
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Ａｄｅｋａ スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
WO2007132478A2 (en) 2006-05-11 2007-11-22 Ind-Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
AU2007270897A1 (en) * 2006-07-03 2008-01-10 Generics [Uk] Limited Novel process for the preparation of bisphosphonic acids
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100878034B1 (ko) * 2007-05-15 2009-01-13 주식회사 대희화학 결정상 리세드로네이트 모노소듐 모노하이드레이트 및 이의제조방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
DE102007030370A1 (de) 2007-06-29 2009-01-02 Ratiopharm Gmbh Essigsäure-Solvate von Risedronat, Polymorph hiervon, deren Herstellung und Verwendung sowie pharmazeutische Zusammensetzung, enthaltend diese
KR100925835B1 (ko) * 2007-12-07 2009-11-06 동우신테크 주식회사 리세드로네이트 나트륨 무수물 및 수화물의 제조방법
KR101010062B1 (ko) 2008-04-11 2011-01-21 주식회사 대희화학 증발 결정화를 이용한 결정상 리세드로네이트 모노소듐모노하이드레이트의 제조방법
CN103588653B (zh) * 2010-10-01 2015-04-22 山东绿叶制药有限公司 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用
CR20160222U (es) 2013-11-15 2016-08-26 Akebia Therapeutics Inc Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US6096342A (en) * 1997-03-12 2000-08-01 The Procter & Gamble Company Dosage forms of risedronate
WO1993009785A1 (en) * 1991-11-22 1993-05-27 Procter & Gamble Pharmaceuticals, Inc. Risedronate delayed-release compositions
PL337813A1 (en) * 1997-06-11 2000-09-11 Procter & Gamble Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
US6432932B1 (en) * 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato

Also Published As

Publication number Publication date
JP2005529103A (ja) 2005-09-29
AU2003209167A1 (en) 2003-10-27
EP1492502A4 (en) 2006-08-16
WO2003086355A1 (en) 2003-10-23
KR20040101447A (ko) 2004-12-02
JP3803672B2 (ja) 2006-08-02
KR100937184B1 (ko) 2010-01-19
CN1658842A (zh) 2005-08-24
IL164382A0 (en) 2005-12-18
KR20070120618A (ko) 2007-12-24
HRP20041051A2 (en) 2005-02-28
KR100919656B1 (ko) 2009-09-30
US20030195170A1 (en) 2003-10-16
CN101024654A (zh) 2007-08-29
MXPA04010009A (es) 2005-07-01
EP1492502A1 (en) 2005-01-05
KR20090019921A (ko) 2009-02-25
CA2480764A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
EP1492502A4 (en) NOVEL POLYMORPHS AND PSEUDOPOLYMORPHS OF SODIUM RISEDRONATE
AU2003205950A8 (en) Placement of alternative advertisements
EP1577280A4 (en) DEUTERATION PROCESS
EP1488046A4 (en) CONSTRUCTION METHODS
AU2003297693A8 (en) Splice variant of human sodium iii channel (hnaiii18)
AU148927S (en) Section of an orthotic insert
AU2003262141A8 (en) Preperation of desloratatine
AU2003298725A8 (en) Preparation of metallotexaphyrins
EP1551573A4 (en) TREATMENT OF MELTED PRODUCTS
PL356853A1 (pl) Zastosowanie bakteriofagów
GB2393207B (en) Means of assembly
IL165356A0 (en) Preparation of 4-haloalkylkylnicotinamides
AU2003280985A1 (en) Regulation of human tripeptidyl peptidase ii
GB0210561D0 (en) Wings of icauras
SI1537210T1 (sl) Lazna oligonukleotidna inhibicija ekspresije CD40
TW579846U (en) Improved structure of wheelchair
TW579826U (en) Structure of retainer
AU148928S (en) Section of an orthotic insert
TW578531U (en) Improved structure of curtain
TW551140U (en) Improved structure of medical gloves
TW533774U (en) Structure improvement of flyswatter
TW566199U (en) Structure of earplug
TW543424U (en) Improved structure of hanger
TW587476U (en) Improved structure of spinning-top
AU153628S (en) Set of frames

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)